Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07483268 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Start date changed from estimate of Jun 2026 to May 29, 2026
    • Site contact updated
    • Study title shortened, about 1 word
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with CRSwNP.
Trial Details
NCT Number NCT07483268
Lead Sponsor Chengdu Kangnuoxing Biopharma,Inc.
Conditions
(from sponsor)		 CRSWNP
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov